vs
Side-by-side financial comparison of Enhabit, Inc. (EHAB) and PROSPERITY BANCSHARES INC (PB). Click either name above to swap in a different company.
PROSPERITY BANCSHARES INC is the larger business by last-quarter revenue ($367.6M vs $270.4M, roughly 1.4× Enhabit, Inc.). PROSPERITY BANCSHARES INC runs the higher net margin — 31.6% vs -14.3%, a 45.9% gap on every dollar of revenue. Over the past eight quarters, PROSPERITY BANCSHARES INC's revenue compounded faster (19.2% CAGR vs 1.5%).
Enhabit, Inc., is a Dallas, Texas-based provider of home health and hospice services. The company operates 255 home health and 110 hospice locations in 34 states with a concentration in Texas, Alabama, Florida, Georgia, Oklahoma and Mississippi. Enhabit is the fourth-largest provider of home health services in the United States and is a leading provider of hospice services. The company was formed in 2022 when Encompass Health spun off its home health and hospice business.
Prosperity Bancshares, Inc. is a bank holding company headquartered in Houston, Texas with operations in Texas and central Oklahoma. As of December 31, 2019, the company operated 285 branches: 65 in the Houston area, including The Woodlands, Texas; 30 in South Texas, including Corpus Christi, Texas and Victoria, Texas; 75 in the Dallas–Fort Worth metroplex; 22 in East Texas; 29 in Central Texas, including Austin, Texas and San Antonio; 34 in West Texas, including Lubbock, Texas, Midland–Odess...
EHAB vs PB — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $270.4M | $367.6M |
| Net Profit | $-38.7M | $116.3M |
| Gross Margin | — | — |
| Operating Margin | -12.3% | — |
| Net Margin | -14.3% | 31.6% |
| Revenue YoY | 4.7% | — |
| Net Profit YoY | 15.9% | -10.7% |
| EPS (diluted) | $-0.76 | $1.16 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $367.6M | ||
| Q4 25 | $270.4M | $275.0M | ||
| Q3 25 | $263.6M | $273.4M | ||
| Q2 25 | $266.1M | $267.7M | ||
| Q1 25 | $259.9M | $265.4M | ||
| Q4 24 | $258.2M | $267.8M | ||
| Q3 24 | $253.6M | $261.7M | ||
| Q2 24 | $260.6M | $258.8M |
| Q1 26 | — | $116.3M | ||
| Q4 25 | $-38.7M | $139.9M | ||
| Q3 25 | $11.1M | $137.6M | ||
| Q2 25 | $5.2M | $135.2M | ||
| Q1 25 | $17.8M | $130.2M | ||
| Q4 24 | $-46.0M | $130.1M | ||
| Q3 24 | $-110.2M | $127.3M | ||
| Q2 24 | $-200.0K | $111.6M |
| Q1 26 | — | — | ||
| Q4 25 | -12.3% | 65.1% | ||
| Q3 25 | 6.4% | 64.4% | ||
| Q2 25 | 6.3% | 64.3% | ||
| Q1 25 | 6.1% | 62.7% | ||
| Q4 24 | -16.0% | 62.0% | ||
| Q3 24 | -38.6% | 62.1% | ||
| Q2 24 | 4.3% | 55.2% |
| Q1 26 | — | 31.6% | ||
| Q4 25 | -14.3% | 50.9% | ||
| Q3 25 | 4.2% | 50.3% | ||
| Q2 25 | 2.0% | 50.5% | ||
| Q1 25 | 6.8% | 49.1% | ||
| Q4 24 | -17.8% | 48.6% | ||
| Q3 24 | -43.5% | 48.6% | ||
| Q2 24 | -0.1% | 43.1% |
| Q1 26 | — | $1.16 | ||
| Q4 25 | $-0.76 | $1.48 | ||
| Q3 25 | $0.22 | $1.45 | ||
| Q2 25 | $0.10 | $1.42 | ||
| Q1 25 | $0.35 | $1.37 | ||
| Q4 24 | $-0.92 | $1.36 | ||
| Q3 24 | $-2.20 | $1.34 | ||
| Q2 24 | $0.00 | $1.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $43.6M | — |
| Total DebtLower is stronger | $426.0M | — |
| Stockholders' EquityBook value | $534.0M | $8.2B |
| Total Assets | $1.2B | $43.6B |
| Debt / EquityLower = less leverage | 0.80× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $43.6M | — | ||
| Q3 25 | $56.9M | — | ||
| Q2 25 | $37.1M | — | ||
| Q1 25 | $39.5M | — | ||
| Q4 24 | $28.4M | — | ||
| Q3 24 | $45.7M | — | ||
| Q2 24 | $28.5M | — |
| Q1 26 | — | — | ||
| Q4 25 | $426.0M | — | ||
| Q3 25 | $441.5M | — | ||
| Q2 25 | $456.9M | — | ||
| Q1 25 | $467.3M | — | ||
| Q4 24 | $492.6M | — | ||
| Q3 24 | $502.9M | — | ||
| Q2 24 | $512.7M | — |
| Q1 26 | — | $8.2B | ||
| Q4 25 | $534.0M | $7.6B | ||
| Q3 25 | $566.8M | $7.7B | ||
| Q2 25 | $552.4M | $7.6B | ||
| Q1 25 | $543.2M | $7.5B | ||
| Q4 24 | $523.5M | $7.4B | ||
| Q3 24 | $566.1M | $7.4B | ||
| Q2 24 | $674.3M | $7.3B |
| Q1 26 | — | $43.6B | ||
| Q4 25 | $1.2B | $38.5B | ||
| Q3 25 | $1.2B | $38.3B | ||
| Q2 25 | $1.2B | $38.4B | ||
| Q1 25 | $1.2B | $38.8B | ||
| Q4 24 | $1.2B | $39.6B | ||
| Q3 24 | $1.3B | $40.1B | ||
| Q2 24 | $1.4B | $39.8B |
| Q1 26 | — | — | ||
| Q4 25 | 0.80× | — | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.83× | — | ||
| Q1 25 | 0.86× | — | ||
| Q4 24 | 0.94× | — | ||
| Q3 24 | 0.89× | — | ||
| Q2 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.4M | — |
| Free Cash FlowOCF − Capex | $3.3M | — |
| FCF MarginFCF / Revenue | 1.2% | — |
| Capex IntensityCapex / Revenue | 0.4% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $65.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $4.4M | $78.3M | ||
| Q3 25 | $37.8M | $194.8M | ||
| Q2 25 | $10.6M | $98.2M | ||
| Q1 25 | $17.9M | $178.2M | ||
| Q4 24 | $-4.1M | $-205.8M | ||
| Q3 24 | $28.4M | $274.6M | ||
| Q2 24 | $9.6M | $216.5M |
| Q1 26 | — | — | ||
| Q4 25 | $3.3M | $68.5M | ||
| Q3 25 | $36.2M | $185.7M | ||
| Q2 25 | $8.7M | $91.8M | ||
| Q1 25 | $17.6M | $171.1M | ||
| Q4 24 | $-4.7M | $-210.7M | ||
| Q3 24 | $27.7M | $270.2M | ||
| Q2 24 | $8.9M | $211.8M |
| Q1 26 | — | — | ||
| Q4 25 | 1.2% | 24.9% | ||
| Q3 25 | 13.7% | 67.9% | ||
| Q2 25 | 3.3% | 34.3% | ||
| Q1 25 | 6.8% | 64.5% | ||
| Q4 24 | -1.8% | -78.7% | ||
| Q3 24 | 10.9% | 103.3% | ||
| Q2 24 | 3.4% | 81.8% |
| Q1 26 | — | — | ||
| Q4 25 | 0.4% | 3.6% | ||
| Q3 25 | 0.6% | 3.3% | ||
| Q2 25 | 0.7% | 2.4% | ||
| Q1 25 | 0.1% | 2.7% | ||
| Q4 24 | 0.2% | 1.8% | ||
| Q3 24 | 0.3% | 1.7% | ||
| Q2 24 | 0.3% | 1.8% |
| Q1 26 | — | — | ||
| Q4 25 | — | 0.56× | ||
| Q3 25 | 3.41× | 1.42× | ||
| Q2 25 | 2.04× | 0.73× | ||
| Q1 25 | 1.01× | 1.37× | ||
| Q4 24 | — | -1.58× | ||
| Q3 24 | — | 2.16× | ||
| Q2 24 | — | 1.94× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EHAB
| Third Party Payor Medicare | $111.6M | 41% |
| Third Party Payor Medicare Advantage | $67.5M | 25% |
| Hospice Segment | $63.6M | 24% |
| Third Party Payor Managed Care | $24.9M | 9% |
| Third Party Payor Medicaid | $1.7M | 1% |
PB
| Net Interest Income | $321.1M | 87% |
| Noninterest Income | $46.5M | 13% |
